🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Belgium / NCT07145671
Active, not recruiting Not applicable

The COCCOS Study: a Transition Program for Young Persons With Chronic Conditions

NCT07145671 · tracked via the Priya Life Science Belgium tracker
Phase
Not applicable
Started
2025-03-13
Last updated
2026-09-11

Condition(s) studied

Type 1 Diabetes MellitusObesityAsthma

Investigational drug(s) / intervention(s)

Transition program

Transition program: Transition Consultation: Pediatric HCP introduces the transition process to AYA and family. A contact person is assigned (ideally the AYA's trusted HCP), along with someone from the AYA's personal network. Key points are recorded in the Individualized Transition Plan (ITP). Independent Visit: AYA has a solo consultation (parents briefly step out). They complete the Ready Steady Go checklist. The ITP is updated, and concerns are discussed. Joint Consultation: Pediatric and adult HCPs meet with the AYA. A new adult contact is assigned, and the AYA picks a pediatric contact for feedback. Checklist is completed again. Feedback Moment: After transfer, the pediatric contact checks in. The checklist guides discussion; feedback is shared across teams, and follow-up arranged if needed.

Study summary

A study is undertaken to examine the feasibility of the newly developed transition program in adolescents with type 1 diabetes, asthma and obesity in a multicentric setting. Specific objectives for this study are: (1) examining the impact of the program in terms of patient-reported health outcomes, (2) examining patients' and healthcare providers' experiences related to the program implementation process, and (3) examining the impact of the program in terms of cost-effectiveness.

Eligibility

Sex
ALL
Min age
16 Years
Max age
19 Years
Healthy volunteers
Accepted
Inclusion criteria: For participants in the intervention group (IG): * 17 years old; * diagnosed with type 1 diabetes, asthma and/or obesity; * who had at least one pediatric outpatient visit, prior to inclusion, in one of both hospitals within the past 12 months; * are Dutch speaking; * planned to transfer to adult care within the next 12 months. For participants in the control group (CG): * age 17,5 and 18 years old, as the control period has a shorter duration (4 months vs. 12 months) * diagnosed with type 1 diabetes, asthma and/or obesity; * who had at least one pediatric outpatient visit, prior to inclusion, in one of both hospitals within the past 12 months; * are Dutch speaking; * planned to transfer to adult care within the next 12 months. Exclusion criteria: Applicable for both CG and IG: \- patients with severe mental, cognitive or neurological problems will be excluded

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Ghent University Hospital Ghent Belgium

More Universiteit Antwerpen trials in Belgium

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07145671 on ClinicalTrials.gov ↗ ← All trials in Belgium